Why the study?
What are the cardiovascular effects of depression and antidepressant treatments in patients with cardiovascular disease?
What are the cardiovascular effects of depression and antidepressant treatments in patients with cardiovascular disease?
Depression is associated with poorer cardiovascular outcomes, and treating it requires careful consideration of the interplay between antidepressant and cardiovascular medications.
Answers are grounded in this paper and cite their sources.
Depression warrants assessment in CVD patients; leaves open optimal antidepressant selection pending targeted trials.
Cardiovascular disease and depression are intimately related illnesses. Cardiovascular mortality is more common in persons with depression, and depression following a myocardial infarction is associated with significantly poorer cardiac outcome. Safe and effective simultaneous treatment of depression and cardiovascular illness can be difficult because of the interplay between these conditions. We examine the evidence for cardiovascular effects of depression, as well as the proposed mechanism for these effects. We also review the cardiovascular effects of antidepressant treatments and the mood-altering effects of common cardiovascular medications. Articles reviewed were derived from a Medline search of English-language articles published between 1970 and 1998 (search terms: cardiovascular disease, antidepressants, psychiatry, myocardial infarction, antihypertensive agents, depression).
No takes yet. Share an insight, caveat, or question.
SHARI H. SEINER (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: